4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank13
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-140.11M
↓ 78% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-78.60M
Historical baseline
PeriodValueYoY Change
2025$-140.11M+12.9%
2024$-160.87M-59.5%
2023$-100.84M+6.2%
2022$-107.49M-50.7%
2021$-71.32M-25.8%
2020$-56.69M-15.0%
2019$-49.31M-416.2%
2018$-9.55M+14.9%
2017$-11.22M-